Memory enhancement

Memory enhancement refers to the biological and pharmacological improvement of the brain's capacity to encode, store, and retrieve information [3, 9, 11]. It is not a discrete molecular target but rather a multifaceted therapeutic objective achieved by modulating various neurochemical pathways involved in synaptic plasticity and neurotransmission [2, 12, 18]. Key systems targeted for enhancement include the cholinergic system (via acetylcholine receptors), the glutamatergic system (via NMDA and AMPA receptors), and downstream signaling cascades involving cAMP response element-binding protein (CREB) and neurotrophic factors [3, 6, 7]. Clinically, memory enhancement is the primary goal for treating cognitive decline in neurodegenerative diseases like Alzheimer's disease, typically utilizing acetylcholinesterase inhibitors and NMDA receptor antagonists [16, 18]. In addition to clinical applications, the use of 'nootropics' by healthy individuals for cognitive optimization has driven interest in novel targets such as phosphodiesterases and specific epigenetic regulators [12, 19].

Other names

Cognitive enhancementNootropic effectMemory improvementNeurocognitive enhancement

Memory enhancement is achieved by increasing synaptic levels of acetylcholine through enzyme inhibition, modulating glutamatergic signaling via NMDA or AMPA receptor interaction, and promoting synaptic plasticity through intracellular cascades such as the CREB pathway.